Skip to content

Prevalence of Sarcopenia and Its Geriatric Features

Prevalence of Sarcopenia and Its Geriatric Features

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02664376
Enrollment
834
Registered
2016-01-27
Start date
2016-01-01
Completion date
2018-01-18
Last updated
2018-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcopenia

Keywords

sarcopenia, geriatry

Brief summary

The goal of this study is to determine the prevalence of sarcopenia in a geriatric hospital ward. Sarcopenia is defined by a loss of muscle mass, loss of muscle strength and loss of muscle quality. It is a geriatric syndrome that, to this date, is not systematically tracked in clinical practice. In order to detect sarcopenia, the investigators will use the operational definition proposed by the European Working Group (EWGSOP) involving the measure of three parameters, namely the speed of walking, the muscle strength and the measurement of the muscular mass.

Interventions

OTHERSarcopenia detection

The assessment of sarcopenia is performed according to the recommendations of the EWGSOP (European Working Group on Sarcopenia in Older people). Three measurements are made: * Muscle mass measurement by dual energy X-ray absorptiometry (DEXA). * Walking speed measurement * Hand grip test A diagnosis of sarcopenia is established if the walking speed is inferior to 0.8 m/sec, the muscular strength is low and the muscular mass is low. Data regarding the geriatric characteristics of this sarcopenic population will be collected.

Sponsors

Brugmann University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* To be admitted in the unit 83 of the Geriatric Departement of the CHU Brugmann hospital, from 10/01/2016 till 30/03/2017.

Exclusion criteria

* Patients unable to consent or without representatives * Patients unable to perform the hand- grip test, the walk test or measurement of the body components by DEXA * Patients in severe pain * Bedridden patients * Patients for which a clear therapeutic abstention has been established * Language barriere that cannot be overcome * Patients unable to walk without the help of a third person

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of sarcopeniaFrom 10/01/2016 till 30/03/2017 (up to 15 months)Sarcopenia detection will be performed at the end of each hospitalization stay in unit 83 of the CHU Brugmann Hospital (Geriatry Department)

Secondary

MeasureTime frameDescription
Percentage of hospitalized patients unable to perform the sarcopenia detection testFrom 10/01/2016 till 30/03/2017 (up to 15 months)Systematic retrospective review of patients hospitalised in the geriatric ward of the CHU Brugmann hospital during the length of the study, in order to determine the percentage of patients that could not, because of one of more exclusion criteria, perform the sarcopenia detection test.

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026